Foresite, a biotech venture firm, reloads with $900M fund

Foresite Capital, an investment firm that backs life sciences and healthcare companies, has raised a $900 million fund.

The fund, Foresite’s sixth, will invest in companies focused on precision medicine, healthcare delivery and life sciences infrastructure, the San Francisco-based firm said in a statement Wednesday.